Quick Read West Pharmaceutical Services (WST) yields 0.34% but grew dividends 73% since 2016 with a 9% payout ratio. West Pharmaceutical spent $566.6M on buybacks in 2024 versus$59.1M on dividends. Repurchases dominate capital allocation. Operating cash flow fell 15.8% in 2024 to $653.4M while CapEx intensity surged to 57.7% of cash flow. A recent study identified one single habit that doubled Americans’ retirement savings and moved retirement from dream, to reality. Read more here. West Pharma ...